Authors : Olufisayo Idowu. Famuyiwa; Temitope David Ogunleye; Azuka Patrick. Okwuraiwe; Osasenaga Macdonald. Ighodaro; Elizabeth Abodunrin; Chika Aladeokin; Atinke Yusuf

Volume/Issue : Volume 11 - 2026, Issue 2 - February

Google Scholar : https://tinyurl.com/y4y24rdk

Scribd : https://tinyurl.com/nm6surj2

DOI : https://doi.org/10.38124/ijisrt/26feb360

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background: SARS-CoV-2 vaccines have demonstrated effectiveness in preventing COVID-19 infection. However, concerns persist regarding potential adverse effects on kidney and thyroid health in certain populations. While the overall safety and efficacy of the available vaccines have been established, limited research has documented post-vaccination complications involving the kidneys and thyroid. Currently, such adverse effects are rarely reported in our environment. This study investigates the impact of SARS-CoV-2 vaccination on kidney and thyroid functions among healthy individuals in Ibadan, Oyo State.  Methodology: This cross-sectional study was conducted with approval from the Oyo State Ethical Board. The participants included a total of 168 healthy individuals, consisting of 82 who had received the SARS-CoV-2 vaccine and 86 who had not, with ages ranging from 18 to 65 years. Sociodemographic information was collected using a structured questionnaire. Blood samples (10 milliliters) were taken to measure serum levels of thyroid-stimulating hormone, free tri-iodothyronine, thyroxine, urea, creatinine, C-reactive protein (CRP), glycated hemoglobin, and SARS-CoV-2 antibodies, employing standard laboratory procedures. The data were analyzed statistically, revealing no significant differences (p > 0.05) between the vaccinated and unvaccinated groups in the mean levels of CRP, glycated hemoglobin, kidney function markers, and thyroid function markers, all of which remained within normal reference ranges.  Results: Both groups exhibited values within normal reference ranges. There were no statistically significant differences in markers of kidney or thyroid function (p > 0.05). C-reactive protein (CRP) levels were lower among vaccinated participants (0.7 ± 0.8 mg/L) compared to controls (1.4 ± 1.7 mg/L), although this difference was not statistically significant. Cystatin-C concentrations were slightly higher in the vaccinated group (0.8 ± 0.2 mg/dL) than in controls (0.7 ± 0.2 mg/dL). Prevalence assessments showed only a small percentage (1.2%) with mild elevations in CRP, FT4, or TSH.  Conclusion: COVID-19 vaccination did not adversely affect renal or thyroid function in apparently healthy individuals. Minor deviations were rare and clinically insignificant, reinforcing vaccine safety.

References :

1. Chen S, Yuan J, Zhang Z, Xu J. Comparing the value of cystatin C and serum creatinine for evaluating renal function and prognosis in COVID-19 patients. Front Pharmacol. 2021; 12:587816. doi:10.3389/fphar.2021.587816.
2. Mohammed, I., Nauman, A., Paul, P., Ganesan, S., Chen, K. H., Jalil, S. M. S., … Zakaria, D. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Human Vaccines & Immunotherapeutics, 2022, 18(1). https://doi.org/10.1080/21645515.2022.2027160
3. Biology Insights. (2025, August 1). How thyroid and kidney function are connected. Biology Insights. https://biologyinsights.com/how-thyroid-and-kidney-function-are-connected
4. Bomback AS, Kudose S, D’Agati VD. De novo and relapsing glomerular diseases after COVID-19 vaccination: What do we know so far? Am J Kidney Dis. 2021;78(4):477–480. doi: 10.1053/j.ajkd.2021.07.003.
5. Yorulmaz G, Tekin MS. SARS-CoV-2 vaccine-associated subacute thyroiditis. J Endocrinol Invest. 2022; 45:1341–1347. doi:10.1007/s40618-022-01767-w.
6. U.S. Food and Drug Administration. Emergency use authorization for Pfizer-BioNTech COVID-19 vaccine. FDA. 2020. Available from: https://www.fda.gov
7. Klomjit N, Alexander MP, Fervenza FC, et al. COVID-19 vaccination and glomerulonephritis: A report of 13 cases. Kidney Int. 2022;101(4):829–833. doi: 10.1016/j.kint.2022.01.013.
8. Lui DTW, Lee CH, Chow WS. Effect of COVID-19 vaccines on thyroid function and autoimmunity. J Clin Endocrinol Metab. 2022;107(9): e3781–e3789. doi:10.1210/clinem/dgac355.
9. Coperchini F, Chiovato L, Croce L, et al. Subacute thyroiditis after SARS-CoV-2 vaccination: A systematic review. Front Endocrinol. 2022; 13:900964. doi:10.3389/fendo.2022.900964.
10. Ippolito S, Dentali F, Tanda ML. SARS-CoV-2 vaccine-associated thyroiditis: A case series. J Endocrinol Invest. 2022;45(5):1189–1195. doi:10.1007/s40618-021-01612-9.
11. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to autoimmune diseases. Clin Immunol. 2020; 217:108480. doi: 10.1016/j.clim.2020.108480.
12. Rotondi M, et al. Bystander activation in autoimmune thyroiditis. Clin Endocrinol. 2018;89(3):351–359. doi:10.1111/cen.13756.
13. Shoenfeld Y, Agmon-Levin N. ‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8. doi: 10.1016/j.jaut.2010.07.003.
14. World Health Organization. COVID-19 vaccine global uptake statistics. WHO. 2022. Available from: https://www.who.int
15. Gor S, et al. C-reactive protein rise in rheumatology patients following COVID-19 vaccination. Rheumatol Adv Pract. 2023;7(Suppl 1): i2–i5. doi:10.1093/rap/rkad005.
16. Matuszewski M, et al. Prognostic performance of cystatin C in COVID-19: A systematic review and meta-analysis. Int J Environ Res Public Health. 2022;19(21):14607. doi:10.3390/ijerph192114607.
17. Pacheco, I. C. R., Costa, D. M. N., Sousa, D. S., Filho, N. S., Silva, G. E. B., & Neves, P. D. M. M. (2022). Kidney injury associated with COVID-19 infection and vaccine: A narrative review. Frontiers in Medicine, 9, 956158.
18. K. N. Lai, Pathogenesis of IgA Nephropathy. Nat. Rev. Nephrol, (8), 2012, 275–283.
19. Ippolito S, Dentali F, Tanda ML. SARS-CoV-2 vaccination and thyroiditis: a review of the literature. Endocrine. 2022;76(2):284‑91.